Characterization of CRTAM gene promoter: AP-1 transcription factor control its expression in human T CD8 lymphocytes

Molecular Immunology

Volumn 46, Issue 16, 2009, Pages 3379-3387

  Valle Rios, Ricardo ^a   Patiño Lopez, Genaro ^a,b   Medina Contreras, Oscar ^a   Canche Pool, Elsy ^a,b   Recillas Targa, Felix ^c   Lopez Bayghen, Esther ^a   Zlotnik, Albert ^d   Ortiz Navarrete, Vianney ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; CRTAM; Human T cells; JNK; Promoter; Transcription

Indexed keywords

ADENINE; CELL ADHESION MOLECULE; CIS ACTING ELEMENT; CYTOTOXIC AND REGULATORY T CELL MOLECULE; DNA; GAMMA INTERFERON; GUANINE; INTERLEUKIN 17; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NECTIN 2; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CODON; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MUTATIONAL ANALYSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANTHRACENES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULINS; INTERFERON-GAMMA; INTERLEUKIN-17; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE 4; MEMBRANE PROTEINS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 70349464687     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.07.016     Document Type: Article

References (28)

1. Arase N., Takeuchi A., Unno M., Hirano S., Yokosuka T., Arase H., and Saito T. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells. Int. Immunol. 17 (2005) 1227-1237
2. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13681-13686
3. Boles K.S., Barchet W., Diacovo T., Cella M., and Colonna M. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood 106 (2005) 779-786
4. Cao H., Widlund H.R., Simonsson T., and Kubista M. TGGA repeats impair nucleosome formation. J. Mol. Biol. 281 (1998) 253-260
5. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
6. Dermitzakis E.T., Reymond A., and Antonarakis S.E. Conserved non-genic sequences-an unexpected feature of mammalian genomes. Nat. Rev. Genet. 6 (2005) 151-157
7. Dustin M.L. Synaptic asymmetry to go. Cell 132 (2008) 733-734
8. Dustin M.L.C.A. Signaling takes shape in the immune system. Cell 103 (2000) 283-294
9. Foletta V.C., Segal D.H., and Cohen D.R. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 63 (1998) 139-152
10. Frazer K.A., Pachter L., Poliakov A., Rubin E.M., and Dubchak I. VISTA: computational tools for comparative genomics. Nucleic Acids Res. 32 (2004) W273-W279
11. Galibert L., Diemer G.S., Liu Z., Johnson R.S., Smith J.L., Walzer T., Comeau M.R., Rauch C.T., Wolfson M.F., Sorensen R.A., Van der Vuurst de Vries A.R., Branstetter D.G., Koelling R.M., Scholler J., Fanslow W.C., Baum P.R., Derry J.M., and Yan W. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J. Biol. Chem. 280 (2005) 21955-21964
12. Ganapathi M., Singh G.P., Sandhu K.S., Brahmachari S.K., and Brahmachari V. A whole genome analysis of 5′ regulatory regions of human genes for putative cis-acting modulators of nucleosome positioning. Gene 391 (2007) 242-251
13. Glimcher L.H., Townsend M.J., Sullivan B.M., and Lord G.M. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4 (2004) 900-911
14. Huang Y., and Wang R.L. T cell receptor signaling: beyond complex complexes. J. Biol. Chem. 279 (2004) 28827-28830
15. Jain J., Valge-Archer V.E., and Rao A. Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol. 148 (1992) 1240-1250
16. Kennedy J., Vicari A.P., Saylor V., Zurawski S.M., Copeland N.G., Gilbert D.J., Jenkins N.A., and Zlotnik A. A molecular analysis of NKT cells: identification of a class-I restricted T cell-associated molecule (CRTAM). J. Leukoc. Biol. 67 (2000) 725-734
17. Lindstein T., June C.H., Ledbetter J.A., Stella G., and Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244 (1989) 339-343
18. Lopez-Bayghen E., Vega A., Cadena A., Granados S.E., Jave L.F., Gariglio P., and Alvarez-Salas L.M. Transcriptional analysis of the 5′-noncoding region of the human involucrin gene. J. Biol. Chem. 271 (1996) 512-520
19. Kronke M., Leonard W.J., Depper J.M., and Greene W.C. Sequential expression of genes involved in human T lymphocyte growth and differentiation. J. Exp. Med. 161 (1985) 1593-1598
20. Patino-Lopez G., Hevezi P., Lee J., Willhite D., Verge G.M., Lechner S.M., Ortiz-Navarrete V., and Zlotnik A. Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes. J. Neuroimmunol. 171 (2006) 145-155
21. Peinado H., Olmeda D., and Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 7 (2007) 415-428
22. Rauscher III F.J., Voulalas P.J., Franza Jr. B.R., and Curran T. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 2 (1988) 1687-1699
23. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., and Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9 (2008) 194-202
24. Tonikian R., Zhang Y., Sazinsky S.L., Currell B., Yeh J.H., Reva B., Held H.A., Appleton B.A., Evangelista M., Wu Y., Xin X., Chan A.C., Seshagiri S., Lasky L.A., Sander C., Boone C., Bader G.D., and Sidhu S.S. A specificity map for the PDZ domain family. PLoS Biol. 6 (2008) e239
25. Wang J., Lee S., Teh C.E., Bunting K., Ma L., and Shannon M.F. The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. Int. Immunol. (2009)
26. Williams T.M., Moolten D., Burlein J., Romano J., Bhaerman R., Godillot A., Mellon M., Rauscher III F.J., and Kant J.A. Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 254 (1991) 1791-1794
27. Yeh J.H., Sidhu S.S., and Chan A.C. Regulation of a late phase of T cell polarity and effector functions by Crtam. Cell 132 (2008) 846-859
28. Zhou X.Y., Yashiro-Ohtani Y., Nakahira M., Park W.R., Abe R., Hamaoka T., Naramura M., Gu H., and Fujiwara H. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. J. Immunol. 168 (2002) 3847-3854